Zynex Inc (ZYXI)

NASDAQ
9.07
-0.30(-3.20%)
After Hours
9.07
0.00(0.00%)
- Real-time Data
  • Volume:
    191,352
  • Day's Range:
    9.03 - 9.72
  • 52 wk Range:
    4.97 - 14.09

ZYXI Overview

Prev. Close
9.37
Day's Range
9.03-9.72
Revenue
143M
Open
9.33
52 wk Range
4.97-14.09
EPS
0.508
Volume
191,352
Market Cap
348.35M
Dividend (Yield)
0.10
(1.00%)
Average Vol. (3m)
206,920
P/E Ratio
18.95
Beta
0.776
1-Year Change
-9.38%
Shares Outstanding
38,406,658
Next Earnings Date
Nov 01, 2022
What is your sentiment on Zynex?
or
Market is currently closed. Voting is open during market hours.

Zynex Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Zynex Inc Analysis

  • 6 Stocks Ready To Run Higher

    1. Ballard Power Systems Ballad Power Systems (NASDAQ:BLDP) looks great and it has been gapping. On Monday, it gapped substantially on contract news, and closed up 2.57, or 14.8%,...

  • 6 Stocks That Could Shoot Higher

    1. Akebia Therapeutics Akebia Therapeautics (NASDAQ:AKBA) actually broke out on Tuesday from a 2-month consolidation, popping 88 cents, or 7%, closing at the session high of the...

Zynex Inc Company Profile

Zynex Inc Company Profile

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellNeutralBuy
Technical IndicatorsStrong SellStrong SellStrong SellBuySell
SummaryStrong SellStrong SellStrong SellNeutralNeutral
  • Hopefully last week was the bottom.
    0
    • how low guys?
      0
      • Goldman sold today massive at offer of 185, not a good sign...
        2
        • Wrong stock, sorry. Ignore this post.
          2
      • Alpha Pro Tech, Ltd. (APT), made face mask, up 16%
        1
        • Takeoff is finally here after months of loading up :)
          0
          • ***stock this do not buy
            2
            • Have the same feeling, every time I buy it falls
              1
            • Long term win
              0
          • what's going on. Stop selling guys.
            0
            • I'm buying more :)
              0
            • yes, great company, with no debt.
              0
          • Whay's the news? Buy?
            0
            • Lowered guidance for Q3.
              0
          • Crazy overreaction.
            0
            • It's mind boggling that such a powerful stock is all of a sudden sinking let alone moving upAnd the company did a public offering of shares
              0